Icon PLC (ICLR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

NEW YORK, NY / ACCESS Newswire / March 17, 2025 / Bernstein Liebhard LLP:Do you, or did you, own shares of ICON plc (NASDAQ:ICLR)?Did you ...

Medidata, a Dassault Systèmes brand and leading provider of clinical trial solutions to the life sciences industry, today announced that ICON plc, (NASDAQ: ICLR) a world-leading clinical research ...

ICON plc, et al., No. 25-cv-00763 ... including shifting part of their clinical studies in-house and away from CROs like ICON. Despite these industry trends, ICON repeatedly represented that client ...

Investors in ICON plc ICLR need to pay close attention to the stock based ... Currently, ICON is a Zacks Rank #4 (Sell) in the Medical Services industry that ranks in the Top 32% of our Zacks Industry ...

Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds ICON plc (“ICON” or the ... cost reduction measures and other industry funding limitations.

About ICON plc ICON plc is a world-leading healthcare ... including current economic and industry conditions. These statements are not guarantees of future performance or actual results, and ...

ICON plc is a world-leading healthcare intelligence and clinical ... including current economic and industry conditions. These statements are not guarantees of future performance or actual results, ...

ICON plc, (NASDAQ: ICLR) a world-leading clinical ... including current economic and industry conditions. These statements are not guarantees of future performance or actual results, and actual ...